535 related articles for article (PubMed ID: 9724117)
21. Repeated operations for infiltrative low-grade gliomas without intervening therapy.
Schmidt MH; Berger MS; Lamborn KR; Aldape K; McDermott MW; Prados MD; Chang SM
J Neurosurg; 2003 Jun; 98(6):1165-9. PubMed ID: 12816258
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
[TBL] [Abstract][Full Text] [Related]
23. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
[TBL] [Abstract][Full Text] [Related]
24. Gliosarcoma in patients under 20 years of age. A clinicopathologic study of 11 cases and detailed review of the literature.
Din NU; Ishtiaq H; Rahim S; Abdul-Ghafar J; Ahmad Z
BMC Pediatr; 2021 Feb; 21(1):101. PubMed ID: 33637068
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy in supratentorial gliomas. A study of 821 cases.
Heesters M; Molenaar W; Go GK
Strahlenther Onkol; 2003 Sep; 179(9):606-14. PubMed ID: 14628126
[TBL] [Abstract][Full Text] [Related]
26. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
[TBL] [Abstract][Full Text] [Related]
27. Gliosarcoma: an audit from a single institution in India of 24 post-irradiated cases over 15 years.
Kumar P; Singh S; Kumar P; Krishnani N; Datta NR
J Cancer Res Ther; 2008; 4(4):164-8. PubMed ID: 19052388
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
[TBL] [Abstract][Full Text] [Related]
29. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
[TBL] [Abstract][Full Text] [Related]
30. Histologically repeatedly confirmed gliosarcoma with long survival: review of the literature and report of a case.
Winkler PA; Büttner A; Tomezzoli A; Weis S
Acta Neurochir (Wien); 2000; 142(1):91-5. PubMed ID: 10664381
[TBL] [Abstract][Full Text] [Related]
31. Congenital gliosarcoma; so-called sarcoglioma.
Ono N; Nakamura M; Inoue HK; Tamura M; Murata M
Childs Nerv Syst; 1990 Nov; 6(7):416-20. PubMed ID: 1669254
[TBL] [Abstract][Full Text] [Related]
32. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
Rodriguez FJ; Scheithauer BW; Giannini C; Bryant SC; Jenkins RB
Cancer; 2008 Nov; 113(10):2779-89. PubMed ID: 18816605
[TBL] [Abstract][Full Text] [Related]
33. Treatment and survival of patients harboring histological variants of glioblastoma.
Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
[TBL] [Abstract][Full Text] [Related]
34. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
[TBL] [Abstract][Full Text] [Related]
35. Secondary gliosarcoma with extra-cranial metastases: a report and review of the literature.
Dawar R; Fabiano AJ; Qiu J; Khushalani NI
Clin Neurol Neurosurg; 2013 Apr; 115(4):375-80. PubMed ID: 22795300
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival in malignant glioma. Prognostic factors.
Phuphanich S; Ferrall S; Greenberg H
J Fla Med Assoc; 1993 Mar; 80(3):181-4. PubMed ID: 8387566
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.
Gannett D; Stea B; Lulu B; Adair T; Verdi C; Hamilton A
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):461-8. PubMed ID: 7673034
[TBL] [Abstract][Full Text] [Related]
38. Gliosarcoma with chondroblastic osteosarcomatous differentation: report of two case with clinicopathologic and immunohistochemical features.
Barut F; Kandemir NO; Ozdamar SO; Gul S; Bektas S; Gun BD; Bahadir B
Turk Neurosurg; 2009 Oct; 19(4):417-22. PubMed ID: 19847765
[TBL] [Abstract][Full Text] [Related]
39. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
[TBL] [Abstract][Full Text] [Related]
40. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection.
Shinoda J; Sakai N; Murase S; Yano H; Matsuhisa T; Funakoshi T
J Neurooncol; 2001 Apr; 52(2):161-71. PubMed ID: 11508816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]